Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences (OACC) Revenue
Annual & quarterly revenue history · segment & region breakdown
OACC · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsOaktree Acquisition Corp. III Life Sciences trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2024 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | — |
| 2024-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Oaktree Acquisition Corp. III Life Sciences receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Oaktree Acquisition Corp. III Life Sciences reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Oaktree Acquisition Corp. III Life Sciences's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
OACC revenue · 4 questionsOACC's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Oaktree Acquisition Corp. III Life Sciences SEC filings · GAAP · Oaktree Acquisition Corp. III Life Sciences SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026